Product NDC: | 0781-5635 |
Proprietary Name: | Pioglitazone hydrochloride and glimepiride |
Non Proprietary Name: | Pioglitazone hydrochloride and glimepiride |
Active Ingredient(s): | 4; 30 mg/1; mg/1 & nbsp; Pioglitazone hydrochloride and glimepiride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-5635 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201049 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130108 |
Package NDC: | 0781-5635-31 |
Package Description: | 30 TABLET in 1 BOTTLE (0781-5635-31) |
NDC Code | 0781-5635-31 |
Proprietary Name | Pioglitazone hydrochloride and glimepiride |
Package Description | 30 TABLET in 1 BOTTLE (0781-5635-31) |
Product NDC | 0781-5635 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pioglitazone hydrochloride and glimepiride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130108 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE |
Strength Number | 4; 30 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |